Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.

Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.

Item

http://www.wikidata.org/entity/Q33276320

Q33276320

about

Intraocular Implants for the Treatment of Autoimmune Uveitis Biomedical Applications of Biodegradable Polymers.Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles.Porous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicin Comparative study to investigate the effect of meloxicam or minocycline HCl in situ gel system on local treatment of periodontal pockets.Development of a regulatable oncolytic herpes simplex virus type 1 recombinant virus for tumor therapy.Novel antibacterial nanofibrous PLLA scaffolds.Novel PLA microspheres with hydrophilic and bioadhesive surfaces for the controlled delivery of fenretinide.Antifungal efficacy of itraconazole-loaded TPGS-b-(PCL-ran-PGA) nanoparticles.Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.Advances in biomimetic regeneration of elastic matrix structures.Biodegradable PLGA-Based Drug Delivery Systems for Modulating Ocular Surface Disease under Experimental Murine Dry Eye Development and evaluation of a novel biodegradable sustained release microsphere formulation of paclitaxel intended to treat breast cancer.Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects Recent advances in polymeric microspheres for parenteral drug delivery--part 1.Treatment modalities and evaluation models for periodontitis The application of microencapsulation techniques in the treatment of endodontic and periodontal diseases.Advanced drug delivery approaches against periodontitis.A mini-review on novel intraperiodontal pocket drug delivery materials for the treatment of periodontal diseases.Advanced biomaterials and their potential applications in the treatment of periodontal disease.Recent advances in testing of microsphere drug delivery systems.Controlled drug delivery from composites of nanostructured porous silicon and poly(L-lactide).Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for breast cancer therapy.Evaluation of cytotoxicity and mechanism of apoptosis of doxorubicin using folate-decorated chitosan nanoparticles for targeted delivery to retinoblastoma In vitro behavior of poly-lactic-co-glycolic acid microspheres containing minocycline, metronidazole, and ciprofloxacin.Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method.Formulation and evaluation of PLA and PLGA in situ implants containing secnidazole and/or doxycycline for treatment of periodontitis.Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium.Evaluation of the Doxycycline Release from AH26 Sealer-Doxycycline Combination: An ex vivo Study Effects of antibiotic physicochemical properties on their release kinetics from biodegradable polymer microparticles.Prolonged delivery of ciprofloxacin and diclofenac sodium from a polymeric fibre device for the treatment of periodontal disease.pH-Sensitive oral insulin delivery systems using Eudragit microspheres.Doxycycline hydrochloride-metronidazole solid lipid microparticles gels for treatment of periodontitis: development, in-vitro and in-vivo clinical evaluation.Synthesis and characterization of biodegradable microcapsules for the controlled delivery of calcium hydroxide.Formulation development of physiological environment responsive periodontal drug delivery system for local delviery of metronidazole benzoate.In situ forming implants for the delivery of metronidazole to periodontal pockets: formulation and drug release studies.Poly(N-vinylcaprolactam-co-methacrylic acid) hydrogel microparticles for oral insulin delivery Silk coating on poly(ε-caprolactone) microspheres for the delayed release of vancomycin Biodegradable Chitosan-g-Poly(methacrylamide) Microspheres for Controlled Release of Hypertensive Drug Rasagiline-encapsulated chitosan-coated PLGA nanoparticles targeted to the brain in the treatment of parkinson's disease

P2860

Q26799168-2E2E3791-7423-44FF-BA02-C6317B6FFB85 Q30426452-4130957E-4C8E-4558-8826-0E53BBCAEF4F Q33477577-0FA8D0EC-F747-4E1D-8A6F-8E2E9D3303E6 Q33932883-A39B5BD8-B7A4-422C-AB0A-E87E8B5C6E27 Q33962520-C7722449-3D96-4489-9572-E8CE0F453BB6 Q34046125-DC60AFCB-AB6D-4A96-9C5E-5A872C6D21CF Q34107698-54A19774-6D16-4136-9181-10B82050CC93 Q34829200-0E80B4F3-E387-4178-8C56-C4E10C7C12D4 Q35110919-B1E4BAC0-F796-4CDE-B47D-E2478D9085E0 Q36371642-4958DD0D-72F2-4CED-9614-31612C24E9D4 Q36552037-0BA1E82C-1440-4DE7-9F97-A352F30A5E89 Q36734622-440CCC66-0EEB-4967-80D5-CA140B393072 Q37254496-08C7C365-15D4-4707-8392-409A7BAAA39E Q37801284-8BE9F5C9-6701-4D7C-B6A0-8B2629E581E9 Q38029806-09D8CC3A-570E-455C-9E61-4AB728BFDFE0 Q38078370-DFDAE375-0FD3-40C0-86C4-7FBFBC4BDBB8 Q38169084-B0730AB1-E930-434B-9AEE-C4D55720BDB3 Q38227459-CEDEF2AD-706C-4DE5-9ECA-99C1FE6428F7 Q38383065-02B836C1-2992-47A4-A0EA-53FD46CF85B2 Q38500275-C67543EE-963B-4E49-8CE9-B673D65CBE6A Q38717509-1C70FE30-053A-47BA-9D44-3D21AC0EFD26 Q39384531-04C0C11F-0BA7-4292-9483-1DC1AB8884DD Q39470022-360FCDD9-9E38-410C-BAE0-A2021E9C57C5 Q39757343-E8740DCB-0CA1-4825-81C2-774FAAA61EAC Q40125974-D0020991-0CC7-4E02-9603-EC3DBB2A35D8 Q40575336-2BAC55DC-3AE6-41A5-A4AC-E5281310A670 Q41809466-E8115414-8918-470B-A328-732D4910608F Q42380474-5525C12A-1CF1-4578-9522-A9E9171CF068 Q42425740-AF3DCE20-CF47-4522-BB29-453F3B41BD86 Q42549724-FA2E9CD8-43C3-438A-B7B9-E661D858C9B7 Q42857811-911FAA67-BFDB-4E0B-A06E-3F3FE92ECBCA Q44548375-21177E8E-E54C-4507-9FFF-B3E4434739CF Q46606911-CD18A309-15FC-42B5-BCF7-9ABACE51A899 Q46735789-03271276-95DB-4B33-8AAE-0EEDD12BE608 Q53649899-E74405D1-4CCC-4C0B-AAA5-3C2F5E25C06F Q53650083-01FE8843-8C9A-4BF8-9253-28EEFA8BEC28 Q57185415-1EA80FC3-41CD-4EF1-802B-EC87678777B9 Q57218823-AA21241F-E25E-482A-83C5-1F53D96737A8 Q57343617-BF4153B7-88EF-45DF-8D21-2BA6408C6FD3 Q57369531-F3BC8401-4591-419C-9AEB-11AE86E3A345

P2860

Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.

Item

http://www.wikidata.org/entity/Q33276320

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu